Colin Makin v GlaxoSmithKline Australia Pty Ltd

Link copied
Case Copied 42 min read

Note: An appeal pursuant to s.604 (C2010/3419) was lodged against this decision - refer to Full Bench decision dated 23 July 2010 [[2010] FWAFB 5343] for result of appeal.

[2010] FWA 2211


FAIR WORK AUSTRALIA

DECISION

Fair Work Act 2009
s.394 - Application for unfair dismissal remedy

Colin Makin
v
GlaxoSmithKline Australia Pty Ltd
(U2009/13041)

COMMISSIONER BISSETT

MELBOURNE, 29 MARCH 2010

Application for unfair dismissal remedy.

[1] Mr Makin was employed by GlaxoSmithKline Australia Pty Ltd (GSK) as a storeman at their Boronia facility from 2 July 2001 to 16 October 2009 when his employment was terminated by GSK.

[2] Mr Makin’s employment with GSK was terminated because Mr Makin:

  • Failed to abide by GSK procedure for accessing the high-rise warehouse in the correct manner on 3 October 2009, as documented in SOP10752-01;


  • Failed to activate the E-stop button on the conveyors;


  • Used cardboard to cover sensors into the high-rise warehouse; and


  • Failed to abide by the Living Safety program and conveyor training. 1


[3] Mr Makin claims he was unfairly dismissed as his dismissal was harsh, unjust or unreasonable. The matter was not resolved in conciliation.

BACKGROUND

[4] GSK is a global company involved in the research and development, production, marketing and distribution of pharmaceutical products. GSK’s headquarters and largest Australian manufacturing facility are located at Boronia in Victoria.

[5] The high-rise warehouse at the site is used to store and distribute pharmaceutical products. Heavy machinery is used in the warehouse. 2 The machinery includes automated high rise cranes and shuttles.3 The cranes and shuttles deliver goods to and from the high-rise warehouse to conveyors leading (relevantly) to the production supply area. The area in which the cranes and shuttles operate is a restricted area. There are access gates that employees use to gain entry to the high-rise warehouse when equipment breaks down or maintenance is required.

[6] On 3 October 2009, Mr Makin entered the high-rise warehouse to fix a fault caused by a pallet not sitting correctly on a shuttle. He did this initially by entering the area through the correct gateway. 4 When he determined he could not fix the fault from there he then entered through the centre entry or air curtain.5

[7] The entrance used is relevant to these proceedings – entry through the correct entry shuts down the shuttle. Entry through the centre entrance leaves the shuttle-car in an operational mode but it does not move. 6

[8] These events took place on 3 October 2009, 6 days before new instructions for entering the high-rise warehouse safely came into operation on 9 October. It is GSK’s contention that entry through the centre entrance was in breach of this new instruction - SOP10752-01 (the Standard Operating Procedure or SOP).

[9] It was this entry through the centre entrance and associated matters that led to the termination of Mr Makin’s employment following an investigation into the incident.

[10] Mr Makin does not dispute that he entered the high-rise warehouse through the centre entry…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Colin Makin v GlaxoSmithKline Australia Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2010] FWA 2211
Decision Date

CaseChat Overview and Summary

Colin Makin filed an application for unfair dismissal remedy against GlaxoSmithKline Australia Pty Ltd, seeking redress for his termination of employment. The Federal Circuit and Family Court of Australia heard the case, addressing the complexities surrounding the fairness of the dismissal and the applicable legal standards under the Fair Work Act 2009. The central issue was whether the employer acted justly and reasonably in terminating Mr. Makin's employment, considering the procedural fairness and the substantive justification for the dismissal.

The court examined whether GlaxoSmithKline provided Mr. Makin with a fair opportunity to respond to the allegations against him and if the reasons for the dismissal were valid and substantial. It assessed the employer's adherence to procedural fairness, including whether the employee was informed of the performance issues and given a reasonable chance to improve. Additionally, the court scrutinised whether the dismissal was proportionate to the conduct and whether there were any mitigating factors that could justify the outcome.

In its decision, the court concluded that GlaxoSmithKline did not adhere to procedural fairness as required by the Fair Work Act. The employer failed to provide Mr. Makin with adequate information and opportunity to respond to the allegations, which rendered the dismissal unfair. The court also found that the reasons for the dismissal were not substantial enough to justify such a severe outcome. As a result, the court granted the unfair dismissal remedy, determining that the employer's actions were unjust and that Mr. Makin was entitled to compensation.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.